Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK
Open Access
- 11 February 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 32 (6), 921-928
- https://doi.org/10.1093/carcin/bgr022
Abstract
Epidemiological studies suggest that coffee consumption reduces the risk of cancers, including colon cancer, but the molecular mechanisms and target(s) underlying the chemopreventive effects of coffee and its active ingredient(s) remain unknown. Based on serving size or daily units, coffee contains larger amounts of phenolic phytochemicals than tea or red wine. Coffee or chlorogenic acid inhibited CT-26 colon cancer cell-induced lung metastasis by blocking phosphorylation of ERKs. Coffee or caffeic acid (CaA) strongly suppressed mitogen-activated MEK1 and TOPK activities and bound directly to either MEK1 or TOPK in an ATP-noncompetitive manner. Coffee or CaA, but not caffeine, inhibited ERKs phosphorylation, AP-1 and NF-κB transactivation and subsequently inhibited TPA-, EGF- and H-Ras-induced neoplastic transformation of JB6 P+ cells. Coffee consumption was also associated with a significant attenuation of ERKs phosphorylation in colon cancer patients. These results suggest that coffee and CaA target MEK1 and TOPK to suppress colon cancer metastasis and neoplastic cell transformation.Keywords
This publication has 43 references indexed in Scilit:
- Coffee consumption and risk of colorectal cancer: A systematic review and meta-analysis of prospective cohort studiesInternational Journal of Cancer, 2009
- Coffee consumption and risk of breast cancer: a metaanalysisAmerican Journal of Obstetrics and Gynecology, 2009
- Coffee drinking and endometrial cancer risk: a metaanalysis of observational studiesAmerican Journal of Obstetrics and Gynecology, 2009
- Coffee Consumption and Risk of Liver Cancer: A Meta-AnalysisGastroenterology, 2007
- Oncogenic Potential of MEK1 in Rat Intestinal Epithelial Cells Is Mediated via Cyclooxygenase-2Gastroenterology, 2005
- Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibitionNature Structural & Molecular Biology, 2004
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- Coffee consumption and risk of type 2 diabetes mellitusThe Lancet, 2002
- Mechanisms of inhibition of the Ras‐MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (‐)‐epigallocatechin‐3‐gallate and theaflavin‐3,3′‐digallate 1The FASEB Journal, 2001
- Polyphenols inhibit promotional phase of tumorigenesis: Relevance of superoxide radicalsNutrition and Cancer, 1998